These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 25339775)

  • 1. Persistent hepatitis C virus infection impairs ribavirin antiviral activity through clathrin-mediated trafficking of equilibrative nucleoside transporter 1.
    Panigrahi R; Chandra PK; Ferraris P; Kurt R; Song K; Garry RF; Reiss K; Coe IR; Furihata T; Balart LA; Wu T; Dash S
    J Virol; 2015 Jan; 89(1):626-42. PubMed ID: 25339775
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HCV infection selectively impairs type I but not type III IFN signaling.
    Chandra PK; Bao L; Song K; Aboulnasr FM; Baker DP; Shores N; Wimley WC; Liu S; Hagedorn CH; Fuchs SY; Wu T; Balart LA; Dash S
    Am J Pathol; 2014 Jan; 184(1):214-29. PubMed ID: 24215913
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ENT1, a ribavirin transporter, plays a pivotal role in antiviral efficacy of ribavirin in a hepatitis C virus replication cell system.
    Iikura M; Furihata T; Mizuguchi M; Nagai M; Ikeda M; Kato N; Tsubota A; Chiba K
    Antimicrob Agents Chemother; 2012 Mar; 56(3):1407-13. PubMed ID: 22232287
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impaired expression of type I and type II interferon receptors in HCV-associated chronic liver disease and liver cirrhosis.
    Chandra PK; Gunduz F; Hazari S; Kurt R; Panigrahi R; Poat B; Bruce D; Cohen AJ; Bohorquez HE; Carmody I; Loss G; Balart LA; Wu T; Dash S
    PLoS One; 2014; 9(9):e108616. PubMed ID: 25265476
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interferon and ribavirin combination treatment synergistically inhibit HCV internal ribosome entry site mediated translation at the level of polyribosome formation.
    Panigrahi R; Hazari S; Chandra S; Chandra PK; Datta S; Kurt R; Cameron CE; Huang Z; Zhang H; Garry RF; Balart LA; Dash S
    PLoS One; 2013; 8(8):e72791. PubMed ID: 24009705
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduced ribavirin antiviral efficacy via nucleoside transporter-mediated drug resistance.
    Ibarra KD; Pfeiffer JK
    J Virol; 2009 May; 83(9):4538-47. PubMed ID: 19244331
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Host-based ribavirin resistance influences hepatitis C virus replication and treatment response.
    Ibarra KD; Jain MK; Pfeiffer JK
    J Virol; 2011 Jul; 85(14):7273-83. PubMed ID: 21543469
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chaperone-Mediated Autophagy Targets IFNAR1 for Lysosomal Degradation in Free Fatty Acid Treated HCV Cell Culture.
    Kurt R; Chandra PK; Aboulnasr F; Panigrahi R; Ferraris P; Aydin Y; Reiss K; Wu T; Balart LA; Dash S
    PLoS One; 2015; 10(5):e0125962. PubMed ID: 25961570
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanism of action of ribavirin in a novel hepatitis C virus replication cell system.
    Mori K; Ikeda M; Ariumi Y; Dansako H; Wakita T; Kato N
    Virus Res; 2011 Apr; 157(1):61-70. PubMed ID: 21320556
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Equilibrative nucleoside transporter 1 expression in primary human hepatocytes is highly variable and determines uptake of ribavirin.
    Baloch K; Chen L; Memon AA; Dexter L; Irving W; Ilyas M; Thomson BJ
    Antivir Chem Chemother; 2017 Apr; 25(1):2-10. PubMed ID: 28417642
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IFN-λ Inhibits MiR-122 Transcription through a Stat3-HNF4α Inflammatory Feedback Loop in an IFN-α Resistant HCV Cell Culture System.
    Aboulnasr F; Hazari S; Nayak S; Chandra PK; Panigrahi R; Ferraris P; Chava S; Kurt R; Song K; Dash A; Balart LA; Garry RF; Wu T; Dash S
    PLoS One; 2015; 10(12):e0141655. PubMed ID: 26657215
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contribution of CNT1 and ENT1 to ribavirin uptake in human hepatocytes.
    Choi MK; Kim MH; Maeng HJ; Song IS
    Arch Pharm Res; 2015; 38(5):904-13. PubMed ID: 25011570
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ribavirin restores IFNα responsiveness in HCV-infected livers by epigenetic remodelling at interferon stimulated genes.
    Testoni B; Durantel D; Lebossé F; Fresquet J; Helle F; Negro F; Donato MF; Levrero M; Zoulim F
    Gut; 2016 Apr; 65(4):672-82. PubMed ID: 26082258
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ribavirin induced hemolysis: a novel mechanism of action against chronic hepatitis C virus infection.
    Soota K; Maliakkal B
    World J Gastroenterol; 2014 Nov; 20(43):16184-90. PubMed ID: 25473172
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ENT1 and treatment of viral diseases.
    Panigrahi R; Dash S
    Oncotarget; 2015 Oct; 6(32):32281-2. PubMed ID: 26431496
    [No Abstract]   [Full Text] [Related]  

  • 16. Influence of a single nucleotide polymorphism at the main ribavirin transporter gene on the rapid virological response to pegylated interferon-ribavirin therapy in patients with chronic hepatitis C virus infection.
    Morello J; Cuenca L; Soriano V; Medrano J; Madejón A; Vispo E; Barreiro P; Labarga P; Jiménez-Nácher I; Rodríguez-Nóvoa S
    J Infect Dis; 2010 Oct; 202(8):1185-91. PubMed ID: 20812847
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Downregulation of autophagy-related gene ATG5 and GABARAP expression by IFN-λ1 contributes to its anti-HCV activity in human hepatoma cells.
    Li X; Li Y; Fang S; Su J; Jiang J; Liang B; Huang J; Zhou B; Zang N; Ho W; Li J; Li Y; Chen H; Ye L; Liang H
    Antiviral Res; 2017 Apr; 140():83-94. PubMed ID: 28131804
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Establishment of hepatitis C virus RNA-replicating cell lines possessing ribavirin-resistant phenotype.
    Satoh S; Mori K; Ueda Y; Sejima H; Dansako H; Ikeda M; Kato N
    PLoS One; 2015; 10(2):e0118313. PubMed ID: 25699517
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of the equilibrative nucleoside transporter 1 on tissue and fetal distribution of ribavirin in the mouse.
    Endres CJ; Moss AM; Ishida K; Govindarajan R; Unadkat JD
    Biopharm Drug Dispos; 2016 Sep; 37(6):336-44. PubMed ID: 27194214
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ribavirin regulates hepatitis C virus replication through enhancing interferon-stimulated genes and interleukin 8.
    Tokumoto Y; Hiasa Y; Uesugi K; Watanabe T; Mashiba T; Abe M; Kumagi T; Ikeda Y; Matsuura B; Onji M
    J Infect Dis; 2012 Apr; 205(7):1121-30. PubMed ID: 22357660
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.